despit
remark
advanc
medic
scienc
infectionassoci
diseas
remain
among
lead
caus
death
worldwid
great
deal
interest
concern
rate
new
pathogen
emerg
caus
signific
human
health
problem
expand
understand
cell
regul
signal
network
defend
invad
retain
cell
homeostasi
reveal
promis
strategi
infect
taken
scientist
decad
appreci
eukaryot
aminoacyltrna
synthetas
arss
play
role
global
cell
signal
mediat
regul
cell
homeostasi
beyond
intrins
function
protein
synthesi
enzym
recent
discoveri
reveal
ubiquit
express
standbi
cytoplasm
arss
sens
respond
danger
signal
regul
immun
infect
indic
potenti
therapeut
target
infecti
diseas
review
discuss
arsmedi
antiinfecti
signal
emerg
role
arss
antimicrobi
immun
contrast
abil
defend
infect
host
arss
inevit
coopt
virus
surviv
propag
therefor
provid
brief
overview
commun
virus
ar
system
final
discuss
encourag
new
approach
develop
arss
therapeut
infecti
diseas
human
come
contact
rang
infecti
microb
includ
bacteria
virus
parasit
divers
safeguard
system
avail
detect
defend
invad
pathogen
upon
recognit
pathogenassoci
molecular
pattern
cell
transmit
intracellular
signal
trigger
immedi
proinflammatori
antimicrobi
respons
innat
immun
respons
first
line
defens
earli
phase
infect
tolllik
receptor
tlr
nodlik
receptor
retino
acidinduc
genei
rigi
like
receptor
repres
famili
innat
immun
receptor
distinguish
microbi
product
nonself
molecul
tlr
group
two
type
depend
cellular
locat
cell
surfac
tlr
endosom
tlr
surfaceexpos
tlr
mainli
detect
bacteri
product
tlr
locat
intracellular
compart
recogn
nucleic
acid
rigi
mediat
antivir
signal
sens
viral
rna
subsequ
interact
central
antivir
signal
protein
mitochondri
antivir
signal
protein
mav
signal
cascad
ultim
lead
transcript
type
interferon
ifn
antivir
molecul
innat
immun
respons
orchestr
earli
host
respons
infect
subsequ
activ
shape
adapt
immun
respons
adapt
immun
system
control
late
phase
infect
gener
immunolog
memori
cellor
b
cellmedi
humor
mechan
wellintegr
defens
system
provid
effect
longlast
protect
immun
induct
mainten
termin
host
immun
respons
infect
must
tightli
control
turn
immun
system
import
turn
avoid
unwant
immun
respons
sever
posit
neg
regulatori
mechan
control
immun
respons
complex
signal
network
number
endogen
protein
either
enhanc
limit
magnitud
durat
inflammatori
respons
regul
system
nonimmun
protein
serv
second
safeguard
system
finetun
host
immun
respons
ensur
cellular
homeostasi
exampl
mitochondri
import
receptor
protein
posit
regul
mav
signal
serv
critic
adaptor
link
mav
downstream
signal
molecul
activ
antivir
immun
altern
cell
develop
divers
strategi
halt
antivir
signal
mav
sever
ligas
includ
ubiquitinprotein
ligas
itchi
homolog
itch
shown
acceler
mav
degrad
viral
infect
collect
cell
employ
multipl
mechan
regul
immun
microbi
invad
help
nonimmunogen
protein
prevent
uncontrol
cellular
damag
aminoacyltrna
synthetas
arss
essenti
compon
translat
everi
live
speci
although
role
arss
protein
synthesi
well
recogn
taken
scientist
decad
acknowledg
role
beyond
translat
appar
propens
new
sequenc
domain
ad
arss
evolut
emerg
new
domain
consist
involv
arss
broad
rang
biolog
function
addit
protein
synthesi
correl
increas
biolog
complex
higher
organ
interestingli
activ
mani
arss
higher
eukaryot
appear
regul
presenc
cytoplasm
multitrna
synthetas
complex
msc
assembl
case
via
append
domain
consist
nine
arss
epr
consist
er
pr
dr
ir
kr
lr
mr
qr
rr
accord
standard
nomenclatur
arss
design
singlelett
amino
acid
code
follow
rs
three
auxiliari
arsinteract
multifunct
protein
aimp
msc
propos
function
depot
system
perform
specif
regulatori
function
via
releas
compon
recent
studi
identifi
novel
molecular
cellular
process
arss
control
host
immun
respons
infect
epr
contribut
innat
antivir
immun
promot
viral
clearanc
msc
protein
also
critic
role
innat
adapt
antivir
immun
influenza
viru
infect
addit
secret
wr
act
earli
warn
signal
host
infect
togeth
find
suggest
arss
may
act
cellular
sensor
well
immunoregul
context
infect
review
provid
overview
current
understand
mechan
ubiquit
nonimmunogen
arss
appropri
regul
cell
signal
upon
infect
also
briefli
discuss
current
strategi
target
pathogen
arss
antibiot
develop
hope
review
stimul
emerg
research
field
arss
infecti
diseas
includ
clinic
applic
arss
antiinfect
pharmacolog
profil
transcript
proteom
chang
infect
cell
provid
key
inform
cellular
factor
may
central
host
immun
respons
multipl
line
evid
support
role
arss
infect
host
group
conduct
rna
sequenc
analysi
human
bronchial
epitheli
cell
infect
influenza
viru
h
h
postinfect
particularli
note
msc
compon
ir
rr
epr
upregul
h
express
kr
gradual
increas
h
respect
nonmsc
ar
gene
earli
induct
observ
yr
tr
sr
wherea
express
wr
gene
increas
h
h
postinfect
geo
access
code
rnaseq
data
agreement
data
anoth
group
show
upregul
influenza
infect
transcriptom
analysi
reveal
close
relat
antivir
immun
microarray
analysi
antigenload
wildtyp
wt
mous
bone
marrowderiv
dendrit
cell
bmdc
show
regul
varieti
immun
process
import
antivir
gene
includ
ifnactiv
gene
ifn
regulatori
factor
gene
innat
immun
sensor
synthas
oa
famili
gene
integr
analysi
microarray
proteom
data
show
hepat
c
viru
hcv
infect
hepatocyt
upregul
wr
sr
alar
tr
gr
gene
express
higher
level
yr
sr
protein
cell
inocul
swine
influenza
viru
wr
upregul
mrna
protein
level
increas
express
wr
also
observ
cell
infect
vibrio
cholera
human
cytomegaloviru
human
hepat
b
viru
microarray
analysi
reveal
upregul
ar
gene
includ
msc
member
ir
lr
mr
rr
epr
well
free
arss
alar
cr
gr
nr
sr
tr
vr
wr
yr
brain
mice
infect
flavivirus
includ
japanes
enceph
viru
west
nile
viru
import
caus
central
nervou
system
diseas
note
studi
perform
rna
analysi
day
postinfect
clinic
symptom
enceph
alreadi
appar
data
indic
arss
respons
infect
may
involv
immun
regul
infect
addit
transcript
proteom
analys
posttransl
modif
ptm
arss
character
respons
variou
stimuli
studi
reveal
divers
extend
function
biolog
patholog
process
phosphoryl
frequent
ptm
occur
ar
protein
thought
induc
structur
chang
may
drive
dissoci
msc
andor
allow
new
interact
partner
well
establish
residu
epr
whep
domain
sequenti
phosphoryl
respons
stimul
induc
phosphoryl
epr
activ
cyclindepend
kinas
indirectli
induc
phosphoryl
via
distinct
kinas
promot
dissoci
epr
msc
subsequ
promot
associ
inhibit
translat
gait
complex
heterotetramer
gait
complex
includ
epr
bind
distinct
region
mrna
involv
chronic
inflamm
suppress
translat
rna
viru
infectionspecif
phosphoryl
also
identifi
epr
residu
modif
critic
dissoci
epr
msc
activ
antivir
signal
infect
caus
massiv
product
divers
cytokin
activ
multipl
cellular
signal
pathway
includ
mitogenactiv
protein
kinas
mapk
cascad
infecti
signal
may
also
indirectli
induc
ptm
ar
protein
case
kr
allergen
stimul
activ
mast
cell
result
phosphoryl
kr
mapkdepend
manner
signal
mapk
kinas
kinas
mek
extracellularrel
kinas
erk
mapk
critic
kr
phosphoryl
ultim
phosphoryl
trigger
dissoci
kr
msc
transloc
nucleu
control
level
diadenosin
tetraphosph
import
signal
molecul
microphthalmiaassoci
transcript
factor
mitf
transcript
activ
therefor
kr
phosphoryl
might
induc
directli
infectionrel
mapk
signal
indirectli
infectioninduc
product
like
cytokin
activ
multipl
regulatori
pathway
collect
chang
express
regul
arss
microbi
infect
suggest
arss
substanti
potenti
regul
pathogenesi
antiinfect
immunolog
respons
arss
ubiquit
abund
protein
therefor
transient
chang
express
may
significantli
affect
global
protein
synthesi
alter
tr
alar
express
markedli
alter
global
protein
synthesi
ptm
locat
addit
domain
vertebr
arss
affect
aminoacyl
enzym
howev
ptm
residu
locat
catalyt
core
domain
influenc
enzymat
activ
arss
phosphoryl
mr
locat
critic
trnabind
site
significantli
downregul
global
translat
inactiv
methioninecharg
activ
damag
dna
repair
look
distinct
transcript
protein
express
profil
arss
well
dynam
regul
ptm
novel
infectionspecif
role
individu
arss
elucid
futur
studi
investig
whether
chang
express
ptm
ar
upon
infect
correl
canon
trna
aminoacyl
activ
global
protein
synthesi
well
noncanon
function
human
epr
one
member
msc
bifunct
enzym
protein
synthesi
compris
er
pr
link
togeth
three
whep
domain
past
two
decad
epr
becom
known
noncanon
function
translat
silenc
form
gait
complex
group
hypothes
cytoplasm
msc
may
function
surveil
system
infect
found
msc
immedi
sens
invas
rna
virus
activ
epr
promot
antivir
immun
via
infectionspecif
phosphoryl
releas
msc
epr
knockdown
macrophag
increas
replic
rna
virus
influenza
viru
vesicular
stomat
viru
reduc
product
antivir
cytokin
convers
ectop
express
epr
macrophag
significantli
attenu
viral
replic
increas
antivir
product
moreov
rna
virus
much
lethal
epr
haploid
mice
due
high
rate
viral
replic
weak
antivir
cytokin
respons
intriguingli
infect
rna
virus
led
previous
unreport
phosphoryl
epr
trigger
releas
epr
msc
phosphoryl
induc
thu
releas
epr
involv
gait
system
instead
epr
associ
poli
rc
bind
protein
wellknown
neg
regul
mav
mediat
degrad
via
ubiquitin
ligas
itch
releas
msc
ultim
phosphoryl
epr
protect
mav
ubiquitin
degrad
stabil
mav
activ
antivir
immun
data
indic
epr
display
phosphocod
control
function
respons
differ
stimuli
furthermor
role
epr
antivir
immun
respons
demonstr
function
signific
msc
immun
regulatori
system
earli
stage
infect
nonenzymat
compon
msc
mainli
associ
rr
qr
anoth
nonenzymat
compon
within
complex
extracellularli
activ
innat
immun
cell
macrophag
monocyt
produc
inflammatori
cytokin
mapk
signal
induc
matur
bmdc
potenti
link
innat
adapt
immun
activ
nk
cell
b
cell
promot
thelper
type
h
cell
immun
express
bmdc
directli
promot
h
cell
polar
character
secret
antigenpres
cell
cell
respect
associ
gener
cellmedi
adapt
immun
respons
adapt
respons
critic
effect
clearanc
intracellular
infect
well
antitumor
immun
lipopolysaccharid
lp
treatment
bmdc
impair
secret
h
polar
cytokin
secret
proinflammatori
cytokin
chang
bmdc
also
express
lower
level
costimulatori
molecul
mhc
class
ii
follow
lp
treatment
mapk
signal
pathway
also
significantli
impair
bmdc
reduc
h
polar
also
critic
innat
adapt
antivir
immun
influenza
viru
infect
microarray
analysi
wt
bmdc
suggest
close
correl
express
antivir
gene
challeng
mice
influenza
viru
aerosol
spray
result
lethal
wherea
wt
mice
show
lethal
high
infecti
dose
median
tissu
cultur
infect
dose
tcid
per
mous
week
postinfect
subleth
dose
tcid
per
mous
still
caus
mortal
among
mice
wt
mice
surviv
evalu
survivor
indic
level
infiltr
neutrophil
macrophag
bronchoalveolar
lavag
fluid
significantli
reduc
mice
day
postinfect
moreov
cell
lung
level
h
antibodi
isotyp
serum
highli
reduc
knockout
mice
day
postinfect
vari
titer
infecti
viru
investig
differ
timepoint
studi
reveal
defici
lead
insuffici
innat
adapt
antivir
immun
respons
vivo
first
report
role
msc
compon
adapt
immun
sequenti
phase
viru
infect
howev
studi
necessari
determin
whether
dissoci
msc
secret
cell
requir
function
viral
infect
whether
function
differ
intracellular
extracellular
environ
infect
also
address
futur
studi
molecular
detail
strengthen
interrel
role
innat
adapt
immun
infecti
diseas
addit
enzymat
activ
human
wr
contain
ntermin
extens
whep
domain
wr
exist
two
differ
form
major
form
fulllength
wr
fwr
aa
form
truncat
version
miniwr
aa
ntermin
whep
domain
delet
altern
splice
form
wr
secret
variou
cell
fwr
cleav
aa
aa
possess
angiostat
activ
leukocyt
elastas
plasmin
extracellular
space
secret
wr
also
play
import
role
highaffin
trp
uptak
human
cell
link
immun
regul
ahn
et
al
report
critic
role
human
wr
primari
respons
molecul
activ
innat
immun
defens
signal
bacteri
infect
show
fwr
prime
innat
immun
upon
bacteri
infect
although
infect
cell
secret
fwr
miniwr
suggest
ntermin
whep
domain
respons
control
infect
author
show
secret
wr
significantli
increas
sepsi
patient
infect
pathogen
includ
gramneg
bacteria
gramposit
bacteria
fungi
sepsi
patient
steril
inflamm
wr
secret
monocyt
upon
infect
directli
bound
complex
macrophag
activ
phagocytosi
chemokin
product
wr
seem
function
prior
full
activ
immun
respons
infect
cell
secret
occur
rel
earli
around
min
postinfect
much
earlier
product
could
first
detect
min
result
suggest
wr
act
warn
molecul
prime
first
line
defens
signal
invad
microb
interestingli
treatment
human
peripher
blood
mononuclear
cell
pbmc
wr
induc
product
chemokin
recruit
inflammatori
cell
particularli
neutrophil
macrophag
moreov
secret
fwr
increas
phagocyt
cell
number
mice
enhanc
phagocyt
activ
mous
bone
marrowderiv
macrophag
bmdm
furthermor
administr
wr
salmonella
typhimuriuminfect
mice
increas
neutrophil
infiltr
decreas
bacteri
load
spleen
liver
ultim
improv
surviv
infect
mice
would
interest
see
molecular
detail
underli
rapid
infectionspecif
secret
wr
studi
also
requir
identifi
mechan
wr
secret
tightli
control
differ
signal
fig
tabl
summar
immunoregulatori
role
arss
gener
rna
virus
small
genom
limit
protein
synthesi
accordingli
virus
reli
host
translat
system
surviv
replic
unavoid
ar
system
includ
arss
trna
coopt
virus
lie
contrast
immunoregulatori
role
defens
infect
viral
hijack
host
translat
machineri
particularli
ribosom
ar
system
consequ
reduc
host
translat
fidel
methionin
misacyl
increas
cell
expos
variou
virus
includ
adenoviru
vaccinia
viru
case
vaccinia
viru
replic
progeni
assembl
take
place
exclus
cytoplasm
infect
cell
distinct
foci
term
viral
factori
virosom
enrich
viral
dna
protein
interestingli
msc
recruit
activ
viral
translat
site
vaccinia
virusinfect
cell
immunofluoresc
analysi
indic
msc
protein
kr
mr
epr
free
arss
sr
yr
larg
recruit
viral
factori
moreov
upregul
divers
ar
gene
flaviviru
infect
mice
brain
impli
host
arss
may
use
virus
propag
base
observ
flaviviru
shut
host
protein
synthesi
therefor
must
compet
cellular
translat
machineri
limit
factor
although
substrat
specif
ar
sequencedepend
sever
studi
reveal
arss
recogn
plant
viral
rna
differ
sequenc
trna
viral
rna
adopt
structur
mimic
trna
increas
effici
genom
rna
translat
trnalik
structur
tlss
found
end
rna
eight
genera
plant
virus
includ
turnip
yellow
mosaic
viru
brome
mosaic
viru
tobacco
mosaic
viru
tlss
aminoacyl
specif
valin
tyrosin
histidin
mimet
fig
immun
function
arss
viral
infect
releas
epr
msc
exert
antivir
activ
inhibit
mav
degrad
also
promot
antivir
immun
potenti
link
innat
adapt
immun
wr
secret
bacteria
viru
infect
subsequ
prime
innat
immun
via
bind
secret
cytokinelik
arss
display
cognat
stimuli
ar
function
repres
arrow
differ
color
see
text
detail
activ
strateg
valuabl
virus
evad
host
immun
system
well
increas
translat
effici
structur
analysi
show
viral
tl
bind
ar
eukaryot
elong
factor
alpha
ribosom
impli
trna
mimicri
function
translat
enhanc
mean
protect
end
viral
genom
rna
similarli
rna
motif
genom
transmiss
gastroenter
coronaviru
form
similar
structur
gait
element
select
interact
epr
sequenc
viral
rna
motif
show
high
ident
known
gait
element
interact
first
second
linker
region
whep
domain
epr
direct
bind
epr
viral
gaitlik
rna
motif
inhibit
translat
viral
rna
motif
vitro
interestingli
viral
gaitlik
rna
motif
affect
host
melanoma
differentiationassoci
protein
mediat
antivir
signal
pathway
although
disrupt
gaitlik
rna
motif
affect
viral
growth
innat
immun
respons
exacerb
activ
indic
motif
interfer
host
defens
system
block
access
epr
host
sensor
viral
rna
retrovirus
util
host
cellular
trna
isoacceptor
primer
revers
transcript
human
immunodefici
use
specif
trna
initi
revers
transcriptasecatalyz
synthesi
minusstrand
dna
viral
assembl
human
kr
found
select
packag
virion
via
direct
interact
viral
gag
protein
truncat
kr
associ
trna
ly
packag
found
within
virion
gag
code
core
structur
protein
viru
fundament
build
block
retroviru
particl
sourc
viral
kr
topic
signific
investig
one
studi
show
incorpor
kr
virion
occur
rapidli
sensit
inhibit
newli
synthes
kr
anoth
studi
suggest
use
host
mitochondri
kr
packag
process
kr
normal
associ
msc
could
exploit
dynam
natur
msc
redirect
coopt
cellular
translat
factor
inde
infect
trigger
releas
kr
msc
possibl
phosphoryl
ptm
import
kr
packag
virion
progeni
viru
infect
free
pool
kr
transloc
nucleu
phosphorylationdepend
manner
although
relev
nuclear
kr
viral
infect
yet
entir
clear
hcv
major
caus
chronic
liver
diseas
character
persist
infect
immun
escap
hcv
envelop
protein
play
import
role
viral
entri
hcv
directli
interact
led
degrad
neg
regul
tumor
growth
decreas
cellular
level
hcv
infect
caus
liver
fibrosi
increas
signal
examin
whether
interact
involv
immun
evas
strategi
hcv
valuabl
recent
shown
exert
antivir
activ
enhanc
h
polar
influenza
viru
encod
nuclear
export
protein
play
import
role
overcom
host
restrict
protein
interact
directli
protect
ubiquitinmedi
degrad
promot
viru
replic
enhanc
stabil
viru
protein
facilit
switch
ubiquitin
sumoyl
collect
data
demonstr
virus
interact
ar
system
sole
coopt
host
translat
machineri
protein
synthesi
instead
virus
also
act
ar
regul
divers
cellular
process
involv
viral
propag
replic
key
player
innat
adapt
immun
system
cytokin
use
therapeut
agent
immunerel
diseas
immunemodulatori
activ
cytokin
repres
promis
featur
antiinfect
therapeut
immun
adjuv
vaccin
direct
pathogen
exampl
proven
clinic
use
viru
infect
induc
ifnstimul
gene
limit
viru
replic
gene
involv
apoptosi
infect
cell
sever
cytokin
tumor
necrosi
produc
precursor
protein
cleav
activ
matur
form
proteas
subsequ
secret
extracellular
space
last
decad
report
sever
arss
secret
intact
cell
function
like
cytokin
arss
secret
respons
extracellular
stimuli
also
secret
continu
suggest
constitut
activ
secret
secret
either
fulllength
truncat
form
gener
altern
splice
proteolyt
cleavag
exhibit
activ
cytokin
signal
pathway
instanc
apoptot
condit
yr
secret
cleav
two
distinct
cytokin
elastas
yield
ntermin
catalyt
domain
miniyr
ctermin
endotheli
monocyteactiv
polypeptid
ii
emapii
like
domain
latter
show
potent
chemotact
activ
leukocyt
monocyt
stimul
product
myeloperoxidas
tissu
factor
wherea
miniyr
function
cytokin
via
gluleuarg
elr
motif
critic
polymorphonuclear
leukocyt
receptor
bind
wr
strong
structur
homolog
yr
discuss
wr
secret
either
fulllength
truncat
form
base
structur
comparison
elr
motif
yr
seem
replac
tyrglytyr
ygi
motif
miniwr
howev
ygi
sequenc
wr
essenti
angiostat
cytokin
activ
instead
import
maintain
structur
stabil
altern
gluhisarg
ehr
contain
eightresidu
motif
aa
miniwr
directli
involv
angiostat
activ
whether
ehr
motif
wr
affect
bind
chemokin
receptor
activ
signal
transduct
investig
extracellular
signal
activ
kr
describ
kr
secret
intact
human
cell
fulllength
form
function
activ
cytokin
secret
kr
bound
monocyt
macrophag
induc
immun
respons
erk
mapk
signal
pathway
induc
releas
endogen
kr
cell
interestingli
shiga
toxin
produc
shigella
dysenteria
subset
diarrheagen
escherichia
coli
trigger
dissoci
kr
msc
secret
macrophag
secret
kr
contribut
shiga
toxinmedi
inflammatori
signal
increas
product
proinflammatori
cytokin
chemokin
target
cell
studi
show
bacteriaderiv
virul
factor
could
use
kr
cytokin
synergist
exacerb
inflammatori
respons
host
hr
secret
fulllength
form
induc
lymphocyt
migrat
activ
monocyt
immatur
dendrit
cell
bind
also
secret
fulllength
form
kda
ctermin
emapii
domain
secret
display
divers
biolog
function
includ
upregul
proinflammatori
gene
activ
immun
cell
emapii
domain
activ
host
immun
respons
act
proinflammatori
cytokin
chemoattract
induc
endothelialmononuclear
cell
migrat
due
specif
cytokinelik
chemotact
activ
secret
arss
great
potenti
boost
immun
primari
infect
altern
block
releas
arss
cell
target
secret
arss
specif
antibodi
inhibitor
could
use
allevi
sever
inflamm
infect
similar
therapi
sepsi
although
mechan
underli
ar
secret
fulli
elucid
recent
studi
show
gr
kr
releas
via
exosom
applic
exosom
pathway
inhibitor
eg
ergolgi
pathway
inhibitor
eg
brefeldin
potenti
strategi
control
ar
secret
attenu
excess
inflamm
induc
infect
extracellular
function
arss
elicit
cytokin
signal
respons
summar
fig
tabl
develop
human
arsderiv
peptid
attract
pharmacolog
approach
rel
safe
well
toler
current
clinic
approach
treat
acut
infect
depend
mainli
use
antibiot
antivir
drug
hostdirect
therapi
augment
antiinfect
respons
greatli
need
arss
bioactiv
role
antiinfecti
signal
repres
potenti
candid
enhanc
host
defens
group
show
eprsderiv
peptid
potenti
therapeut
agent
broad
rang
rna
virus
domain
map
studi
epr
show
epr
region
aa
critic
protect
mav
ubiquitin
activ
antivir
type
ifn
signal
base
observ
antivir
peptid
call
tatepep
design
fuse
epr
region
cellperm
tat
tag
treatment
macrophag
tatepep
increas
product
antivir
cytokin
reduc
rna
viral
replic
vitro
tatepep
shown
increas
mav
stabil
inhibit
neg
regul
cell
examin
antivir
mechan
tatepep
structurebas
modif
peptid
introduc
optim
activ
function
valid
vivo
elr
motif
human
yr
repres
leukocyt
chemoattract
elr
peptid
bind
host
macrophag
intern
lead
enhanc
secret
proinflammatori
cytokin
introduct
yr
elr
motif
yeast
cell
lack
protein
led
gain
cytokin
function
structur
analysi
embed
elr
motif
yr
investig
interact
neighbor
residu
bind
high
affin
chemokin
receptor
case
miniyr
support
develop
motif
therapeut
agent
regul
inflamm
well
angiogenesi
wr
ntermin
region
aa
act
danger
signal
earli
infect
may
also
promis
target
antimicrobi
peptid
direct
bind
ntermin
region
wr
tlr
stimul
antiinfect
immun
respons
host
identif
function
motif
requir
bind
annot
specif
residu
structur
analysi
wr
ntermin
domain
help
us
design
potent
drug
candid
treat
infecti
diseas
overcom
gener
weak
peptid
drug
includ
short
halflif
fast
elimin
low
membran
permeabl
small
synthet
compound
design
base
identifi
ar
peptid
may
offer
effect
solut
develop
antiinfecti
drug
infecti
diseas
monitor
direct
detect
pathogen
howev
antigen
variat
broad
divers
microbi
pathogen
presenc
unknown
antigen
make
difficult
diagnos
exact
type
pathogen
approach
potenti
address
challeng
reli
monitor
express
host
gene
protein
analyz
gene
express
profil
virusinfect
human
blood
show
differ
pathogen
elicit
distinct
host
rna
signatur
host
protein
involv
immun
respons
also
indic
infect
elev
level
factor
provid
use
clinic
inform
context
infecti
diseas
exampl
detect
concentr
three
protein
tumor
necrosi
factorrel
apoptosisinduc
ligand
trail
interferoninduc
protein
creactiv
protein
crp
could
use
discrimin
bacteri
viral
diseas
reduc
antibiot
misus
high
mobil
group
box
protein
also
import
mediat
inflamm
elev
plasma
level
significantli
associ
infect
close
correl
secret
arss
presenc
infect
observ
previou
studi
wr
detect
supernat
pbmc
cultur
h
bacteri
infect
detect
period
result
suggest
compar
secret
rel
late
stage
h
exposur
pathogen
wr
may
use
earli
biomark
infect
moreov
releas
respons
numer
inflammatori
signal
addit
infect
wr
secret
depend
presenc
infect
differenti
sepsi
system
inflammatori
respons
syndrom
therefor
wr
may
use
diagnost
tool
infecti
diseas
includ
sepsi
without
necess
detect
pathogen
antigen
patient
serum
kr
also
secret
intact
human
cell
respons
proinflammatori
cytokin
stimul
product
immun
cell
bacteri
toxin
also
induc
kr
secret
turn
increas
cytokin
product
posit
feedback
loop
augment
kr
signal
infect
may
util
detect
tool
infecti
diseas
type
amount
secret
arss
might
differ
depend
pathogen
durat
infect
classif
detect
arss
human
sampl
provid
valuabl
inform
diseas
statu
anoth
strategi
detect
infect
measur
ar
antibodi
specif
autoantibodi
found
sera
patient
autoimmun
diseas
antisynthetas
syndrom
chronic
autoimmun
condit
caus
product
autoantibodi
eight
differ
arss
antihr
preval
antisynthetas
syndrom
form
idiopath
inflammatori
myopathi
character
myositi
interstiti
lung
diseas
arthriti
although
exact
underli
mechan
syndrom
unknown
seem
occur
certain
viral
infect
exposur
certain
drug
inde
infecti
agent
thought
induc
autoimmun
selftoler
broken
exampl
infecti
myositi
one
symptom
antisynthetas
syndrom
acut
subacut
chronic
infect
skelet
muscl
caus
virus
includ
hiv
bacteria
fungi
parasit
therefor
ar
autoantibodi
may
clinic
use
biomark
infect
final
robust
specif
ar
detect
system
requir
accur
predict
infecti
diseas
purif
human
arss
antigen
specif
design
requir
minim
crossreact
pathogen
arss
contain
conserv
catalyt
region
determin
antigen
specif
base
host
ar
sequenc
structur
improv
ar
detect
sever
ar
antibodi
sandwich
elisa
system
commerci
avail
util
polyclon
antibodi
quit
expens
sensit
suffici
use
human
serum
sampl
high
level
background
overcom
low
resolut
new
diagnost
tool
protein
chip
develop
identifi
multipl
arss
simultan
pcrbase
method
detect
host
arss
also
use
due
high
sensit
specif
ration
design
discrimin
primer
human
arss
promot
time
diagnosi
infect
moreov
addit
secret
arss
examin
host
ar
proteom
genom
signatur
cell
isol
patient
peripher
blood
tissu
help
correl
abnorm
express
arss
infect
collect
arss
novel
biomark
may
use
identifi
earli
secondari
infect
combin
detect
pathogen
antigen
host
arss
specif
involv
infect
improv
current
diagnosi
system
infect
great
deal
interest
concern
rate
new
pathogen
emerg
caus
signific
human
health
problem
among
wide
varieti
factor
predispos
pathogen
invad
host
popul
spread
antibioticresist
bacteria
seriou
challeng
medic
research
inhibit
protein
synthesi
target
trna
aminoacyl
proven
effect
strategi
antipathogen
drug
develop
catalyt
domain
ar
three
distinct
bind
pocket
respons
recognit
amino
acid
adenyl
trna
moieti
base
substratebind
site
three
class
ar
inhibitor
explor
inhibitor
target
singl
specif
pocket
mani
bind
one
site
within
catalyt
domain
separ
edit
domain
firstli
amino
acid
analog
act
competitor
particular
amino
acid
ar
domain
halofuginon
bind
prolineand
trnabind
site
pr
therebi
inhibit
enzymat
activ
use
herbal
medicin
treat
malaria
biosynthet
product
includ
indolmycinchuangxinmycin
tryptophan
analog
cispentacin
icofungipen
isoleucin
analog
ochratoxin
phenylalanin
analog
tyrosin
analog
although
use
therapeut
agent
poor
antibacteri
activ
low
specif
develop
compound
mimic
aminoacyladenyl
aaamp
intermedi
bind
aaamp
pocket
may
also
power
strategi
mupirocin
mimet
isoleucylamp
occupi
aaampbind
site
success
ar
inhibitor
exhibit
high
degre
specif
sever
speci
bacteria
includ
methicillinresist
staphylococcu
aureu
e
coli
bacillu
subtili
clinic
use
mupirocin
valid
idea
arss
effect
antibiot
target
human
patient
lastli
inhibit
fungal
lr
form
proinflammatori
effect
biphas
effect
antiproangiogenesi
emapii
endotheli
monocyteactiv
polypeptid
ii
elr
gluleuarg
ehr
gluhisarg
dc
dendrit
cell
trna
leu
adduct
edit
site
trap
nucleotid
trna
thu
inhibit
subsequ
round
aminoacyl
interestingli
borrelidin
act
tripl
competit
inhibitor
cocryst
structur
borrelidin
tr
show
borrelidin
simultan
occupi
four
distinct
subsit
includ
substratebind
site
amino
acid
atp
trna
thr
addit
bind
site
full
set
arss
present
bacteri
pathogen
offer
great
opportun
develop
divers
antibacteri
targetbas
drug
consider
evolutionari
diverg
prokaryot
eukaryot
arss
may
reduc
potenti
offtarget
effect
ar
inhibitor
bacteri
arss
mani
advantag
druggabl
target
enzym
rel
easi
purifi
recombin
protein
typic
aminoacyl
assay
measur
rate
aatrna
aa
format
kinet
assay
measur
rate
convers
ppi
atp
use
radioisotop
specif
organ
compound
like
malachit
green
avail
earli
character
ar
inhibitor
tradit
approach
identifi
arstarget
drug
would
includ
highthroughput
screen
larg
librari
chemic
bacteriaderiv
natur
product
technolog
advanc
autom
highthroughput
screen
enabl
rapid
effici
inexpens
discoveri
low
molecular
weight
compound
perturb
bacteri
ar
function
potent
inhibitor
aureu
mr
identifi
highthroughput
screen
glaxosmithklin
compound
later
character
quinolinon
deriv
act
competit
methionin
substrat
anacor
also
use
combinatori
screen
boroncontain
small
molecul
librari
discov
novel
synthet
inhibitor
inhibit
fungal
lr
howev
serendipit
discoveri
larg
chemic
librari
would
like
look
needl
haystack
compound
may
high
risk
toxic
would
work
unknown
mechan
structurebas
drug
design
power
approach
drug
develop
techniqu
could
especi
appli
ar
inhibitor
sinc
architectur
ar
catalyt
domain
structur
conserv
throughout
evolut
low
amount
variat
ar
activ
domain
suggest
target
bacteri
arss
may
broad
strategi
use
rang
pathogen
select
eukaryot
prokaryot
arss
might
difficult
achiev
enzym
core
structur
arss
without
addit
domain
usual
present
higher
eukaryot
readili
solubl
mani
uniqu
structur
publicli
avail
protein
data
bank
atomiclevel
character
structureguid
drug
design
critic
develop
modifi
arsbas
drug
cocrystal
arss
inhibitor
clearli
show
small
compound
potent
control
ar
function
across
varieti
speci
detail
structur
function
analysi
bind
natur
product
borrelidin
tr
good
exampl
author
determin
crystal
structur
human
e
coli
tr
complex
borrelidin
found
borrelidin
potent
redund
mechan
inhibit
tr
protein
synthesi
studi
reveal
borrelidin
act
quadrival
inhibitor
fill
three
substratebind
site
extra
space
extend
macrolid
ring
grow
report
crystal
structur
arss
show
detail
catalyt
site
avail
provid
valuabl
inform
drug
design
dock
instead
resolv
cocryst
ar
inhibitor
experiment
new
comput
algorithm
approach
model
ar
drug
interact
becom
indispens
timesav
tool
sever
bioinformat
tool
avail
explor
sequenc
structurederiv
enzym
activ
site
residu
annot
drug
insert
silico
method
includ
virtual
screen
structurebas
drug
design
use
design
ar
inhibitor
target
lr
wr
nr
mr
ir
tr
inhibitori
activ
compound
must
confirm
moreov
ar
substratebas
modif
exploit
structur
trna
consid
trana
discoveri
develop
modern
bioinformat
tool
conduct
detail
analys
trna
employ
highthroughput
screen
system
fluoresc
probe
mimick
tloop
region
identifi
novel
drug
bind
anticodon
stem
loop
region
trna
inhibit
pathogen
growth
addit
despit
structur
homolog
specif
sequenc
differ
prokaryot
eukaryot
arss
use
design
discrimin
specif
arstarget
drug
exampl
success
applic
mupirocin
deriv
mere
twoaminoacid
differ
prokaryot
eukaryot
ar
mutat
analysi
amino
acid
residu
character
critic
site
involv
interact
arss
inhibitor
taken
togeth
integr
divers
method
greatli
enhanc
ration
develop
optim
sophist
ar
inhibitor
meet
need
new
antimicrobi
antifung
antiparasit
drug
unfortun
use
antibiot
inevit
led
bacteri
resist
ar
inhibitor
except
aureu
extraordinarili
adapt
gramposit
pathogen
proven
abil
develop
drug
resist
although
mupirocin
use
treat
methicillinresist
aureu
clinic
mic
strain
appear
evolv
two
type
resist
mupirocin
first
point
mutat
target
aureu
ir
led
develop
lowlevel
mupirocin
mic
antibiot
resist
horizont
gene
transfer
resist
gene
mupa
encod
altern
ir
mupb
contain
common
ir
motif
either
eukaryot
bacteria
caus
highlevel
resist
mupirocin
mic
addit
although
mr
inhibitor
potent
larg
number
pathogen
strain
aureu
enterococcu
streptococcu
pneumonia
exhibit
wide
rang
suscept
compound
pneumonia
strain
encod
second
distantli
relat
mr
enzym
call
resist
synthet
deriv
inhibitor
includ
pneumonia
acquir
gene
horizont
transfer
gramposit
pathogen
close
rel
mani
ar
inhibitor
natur
produc
sever
microb
biosynthes
ar
inhibitor
toxic
sourc
target
arss
bacteria
produc
ar
inhibitor
requir
selfimmun
selfimmun
defin
resist
system
antimicrobi
compound
kill
relat
bacteria
iron
plasmid
encod
resist
gene
usual
gene
encod
secondari
arss
readili
transmiss
conjug
confer
polymicrobi
resist
exampl
pseudomona
fluorescen
produc
mupirocin
quorum
sens
kill
competitor
bacteria
local
environ
p
fluorescen
protect
express
mupm
gene
encod
second
ir
transfer
p
fluorescen
mupm
e
coli
induc
resist
mupirocin
similarli
agrobacterium
radiobact
strain
produc
agrocin
inhibit
plant
pathogen
tumefacien
immun
agrocin
confer
gene
encod
activ
lr
introduct
gene
pathogen
tumefacien
impart
antibiot
resist
suggest
biocontrol
organ
carri
selfprotect
ar
avoid
cell
death
thu
although
arss
good
drug
target
due
high
select
potenc
toward
microb
share
ar
resist
gene
local
among
neighbor
bacteria
also
across
long
distanc
select
pressur
major
obstacl
ar
drug
applic
identif
ar
inhibitor
associ
selfimmun
transfer
natur
resist
gene
identifi
final
base
differ
chemic
properti
arss
target
multipl
arss
simultan
may
safe
way
overcom
emerg
resist
infecti
diseas
remain
evergrow
risk
human
health
due
increas
antibiot
resist
immunecompromis
popul
emerg
new
virus
spread
rapidli
popul
due
global
identif
novel
drug
target
control
complex
infect
situat
inevit
great
import
beyond
role
protein
synthesi
ubiquit
exist
arss
sens
immedi
respond
danger
signal
msc
complex
consist
arss
nonenzymat
protein
regard
hub
cellular
regulatori
function
arss
antiinfect
function
epr
posit
regul
antivir
signal
increas
express
antivir
gene
provid
evid
msc
serv
immun
regulatori
system
infect
addit
nonmsc
protein
wr
consid
primari
defens
molecul
help
cell
immun
system
respond
rapidli
infecti
signal
moreov
secret
arss
evolv
activ
similar
classic
proinflammatori
cytokin
function
demonstr
arss
promis
therapeut
target
boost
defens
immun
respons
control
infecti
pathogen
addit
durat
infect
rang
day
year
screen
ar
express
secret
could
provid
potenti
prognost
maker
acut
chronic
infect
emerg
multidrugresist
microb
substanti
threat
human
health
therapeut
applic
arstarget
inhibitor
offer
altern
drug
overcom
inevit
bacteri
resist
current
use
antibiot
although
known
antivir
drug
target
arss
identif
gaitlik
rna
motif
viral
genom
discoveri
host
arsrna
intermedi
packag
retrovirus
may
offer
new
opportun
develop
antivir
agent
still
limit
studi
avail
efficaci
target
arss
infect
recent
studi
includ
find
provid
new
insight
role
arss
infect
antiinfect
immun
hope
stimul
indepth
research
field
advanc
basic
scienc
clinic
applic
ar
author
declar
conflict
interest
relat
manuscript
